Treatment Trial of Subclinical Hypothyroidism in Down Syndrome
Levothyroxine Treatment and Cardiometabolic Outcomes in Adolescents With Down Syndrome
Sponsor: Children's Hospital of Philadelphia
Listed as NCT01832753, this NA trial focuses on Down Syndrome and Subclinical Hypothyroidism and remains completed. Sponsored by Children's Hospital of Philadelphia, it has been updated 15 times since 2013, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
15 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
▶ Show 10 earlier versions
-
Dec 2021 — Dec 2022 [monthly]
Completed NA
-
Jan 2021 — Dec 2021 [monthly]
Completed NA
-
Oct 2019 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jul 2019 — Oct 2019 [monthly]
Active Not Recruiting NA
-
Nov 2018 — Jul 2019 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Nov 2018 [monthly]
Active Not Recruiting NA
-
Dec 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
-
Jul 2017 — Dec 2017 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Feb 2017 — Jul 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Jan 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Children's Hospital of Philadelphia
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
For direct contact, visit the study record on ClinicalTrials.gov .